Functional Dyspepsia Treatment Using Virtual Reality

Launched by MAYO CLINIC · Apr 28, 2023

Keywords

ClinConnect Summary

**Summary of the Clinical Trial: Functional Dyspepsia Treatment Using Virtual Reality**

This clinical trial is exploring a new way to treat functional dyspepsia, which is a condition that causes discomfort or pain in the upper stomach without a clear medical cause. The researchers want to see if using virtual reality can help improve the symptoms related to this condition. The study is currently recruiting participants who are between the ages of 65 and 74 and those between 27 and 39 years old, regardless of gender.

To join the study, participants need to have been diagnosed with functional dyspepsia based on specific criteria and must have had an upper endoscopy to check for a common stomach infection called Helicobacter pylori. If someone has this infection, they will need to be treated for it before participating. People with certain other medical conditions, such as severe gastrointestinal disorders or those who have had specific surgeries, will not be eligible. Participants can expect to use virtual reality as part of their treatment, but more details on what that involves will be provided during the study. This trial could offer a new and innovative approach to managing symptoms of functional dyspepsia.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Symptoms of dyspepsia thought to represent functional dyspepsia, meeting Rome IV criteria
• • Had an upper endoscopy and assessment for Helicobacter pylori; if a patient is found to have H. pylori, treatment with confirmed eradication (by stool antigen test or urea breath test) will be required before the patient is eligible for study inclusion.
• • Patients will be considered for the study if they have undergone a complete history and physical examination during a previously scheduled consultation/evaluation visit with a gastroenterologist in the Mayo Clinic Florida General GI or Motility clinic.
• Exclusion Criteria:
• • Symptoms are thought to represent an organic disorder (e.g., peptic ulcer disease, hepatitis, pancreatitis, inflammatory bowel disease, type I diabetes, a known malignancy, radiation-induced injury, an active infection, vasculitis, celiac disease), or patients have known uncontrolled GERD, esophagitis, eosinophilic esophagitis, or untreated H. pylori.
• • Patients with gastroparesis or cyclic vomiting syndrome.
• • Patients with prior surgery to the esophagus, stomach or duodenum.
• • Patients taking opioids.
• • Patients with motion sickness, vertigo, or a seizure disorder
• • IBS symptoms are not predominant.

Trial Officials